UVA Health lung cancer specialists will discuss the latest developments in lung cancer management. Bring your questions.
Category: Oncology Innovations
UVA Children's pediatric oncology researchers have developed a molecule to block a key determinant of T-ALL cell survival.
Blue light cystoscopy better pinpoints bladder cancer and improves access to life-saving surveillance after diagnosis.
Through a significant investment over 8 years, we became Virginia's first National Cancer Institute-designated comprehensive cancer center.
This groundbreaking animal-model research moves us closer to understanding why GI health plays a key role in treating breast cancer.
Find out why lymphoma and leukemia patients can mount a protective immune response to coronavirus and other findings from UVA Health experts.
With nationally known urologic oncologists and surgeons, UVA prostate cancer patients get top-level care from a ‘SEAL team’ of specialists.
UVA researchers are evaluating a novel CAR T-cell in order to expand this therapy to treat patients with untreatable lymphomas.
Racial disparities in colon cancer rates occur due to how the colon's different sides age. Current research analyzes why.
UVA research into treating deadly glioblastomas has found an oncogene to target and a way to use focused ultrasound never before possible.